Scott M. Coiante

2023

In 2023, Scott M. Coiante earned a total compensation of $400K as Former Chief Financial Officer at Aprea Therapeutics, a 61% decrease compared to previous year.

Compensation breakdown

Salary$100,000
Other$300,000
Total$400,000

Coiante received $300K in other compensation, accounting for 75% of the total pay in 2023.

Coiante also received $100K in salary.

Rankings

In 2023, Scott M. Coiante's compensation ranked 2,269th out of 2,983 executives tracked by ExecPay. In other words, Coiante earned more than 23.9% of executives.

ClassificationRankingPercentile
All
2,269
out of 2,983
24th
Division
Manufacturing
1,277
out of 1,637
22nd
Major group
Chemicals And Allied Products
758
out of 906
16th
Industry group
Drugs
740
out of 869
15th
Industry
Pharmaceutical Preparations
532
out of 627
15th
Source: SEC filing on April 25, 2024.

Coiante's colleagues

We found two more compensation records of executives who worked with Scott M. Coiante at Aprea Therapeutics in 2023.

2023

John Hamill

Aprea Therapeutics

Chief Financial Officer

2023

Oren Gilad

Aprea Therapeutics

Chief Executive Officer

News

You may also like